Laroxyl

Amitriptyline Hydrochloride, the active ingredient in Laroxyl, is a tricyclic antidepressant presented as an oral tablet for oral use. It is prescribed for major depressive disorder, chronic neuropathic pain and migraine prophylaxis in adult patients.

GNH USA supplies Laroxyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laroxyl, a tricyclic antidepressant, is used to treat several conditions affecting mood and pain pathways.

Major depressive disorder: reduces depressive symptoms and improves mood in adults. Depressive episodes: alleviates acute depressive symptoms during episodic phases. Chronic neuropathic pain: lessens pain intensity and improves functional ability. Migraine prophylaxis: decreases frequency and severity of migraine attacks.

Amitriptyline may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dry mouth - Constipation - Drowsiness or sedation - Weight gain - Blurred vision - Urinary retention

Serious or Rare Side Effects: - Cardiac arrhythmias or conduction abnormalities - Seizures, especially at high doses - Severe hypotension or orthostatic collapse - Suicidal thoughts or behavior - Blood dyscrasias such as agranulocytosis - Hepatic toxicity or elevated liver enzymes

When prescribing Laroxyl, clinicians should consider several safety measures.

Assess cardiac history: evaluate for conduction disorders before initiation. Monitor for suicidal ideation: especially during early treatment or dose changes. Use cautiously in elderly: increased sensitivity to anticholinergic effects. Avoid abrupt discontinuation: taper gradually to reduce withdrawal symptoms. Adjust dose in hepatic impairment: reduce dosage as needed. Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Amitriptyline can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome. - Selective serotonin reuptake inhibitors (SSRIs) or other serotonergic agents: increased serotonin toxicity. - Alcohol or CNS depressants: enhanced sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: additive blood pressure lowering. - Antidiabetic agents: potential hypoglycemia. - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may raise amitriptyline plasma levels.